Failure isn't frowned upon in Silicon Valley. The kind of openness to experimentation and trying new things . . . being prepared to fail and learning from the failure is critical to innovation and inventions,'' said James Gibbons, Stanford's former engineering dean, now the university president's special counsel for industry relations. A failed first try spurred Genentech researchers developing Herceptin, a treatment for advanced breast cancer. The treatment, based on a specially engineered version of the antibodies each person produces to fight diseases, would be rejected by humans because it was created from mice. So researchers adopted a new approach, developing a technique that would trick the human body into accepting the antibodies.
Innovation is a combination of perseverance and, sometimes, pennies in a cup.
The information you receive online from Mercury Center is protected by the copyright laws of the United States. The copyright laws prohibit any copying, redistributing, retransmitting, or repurposing of any copyright - protected material.